Panbela Therapeutics, Inc. (PBLA)
OTCMKTS
· Delayed Price · Currency is USD
0.380
+0.060 (18.75%)
Oct 30, 2024, 3:38 PM EDT
Panbela Therapeutics Employees
As of December 31, 2023, Panbela Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$4,714,000
Market Cap
1.78M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
Panbela Therapeutics News
- 2 months ago - Panbela Therapeutics, Inc. (PBLA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Panbela Therapeutics GAAP EPS of -$1.47 beats by $0.60 - Seeking Alpha
- 2 months ago - Panbela Provides Business Update and Reports Q2 2024 Financial Results - GlobeNewsWire
- 3 months ago - Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024 - GlobeNewsWire
- 4 months ago - Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification - GlobeNewsWire
- 6 months ago - Panbela Therapeutics, Inc. (PBLA) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Panbela Provides Business Update and Reports Q1 2024 Financial Results - GlobeNewsWire
- 6 months ago - Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac - GlobeNewsWire